Patents by Inventor Colin McKinlay

Colin McKinlay has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MRNA treatment nanoparticles
    Patent number: 11879126
    Abstract: Provided herein are examples of mRNA treatment nanoparticles and methods of using them to treat a patient. An mRNA treatment nanoparticle may include one or more mRNAs encoding a tumor-specific antigen and an immunomodulatory agent; and a delivery vehicle molecule encapsulating the one or more mRNAs.
    Type: Grant
    Filed: October 20, 2022
    Date of Patent: January 23, 2024
    Assignee: Nutcracker Therapeutics, Inc.
    Inventors: Samuel Deutsch, Daniel Frimannsson, Nicole Fay, Colin McKinlay, Ole Haabeth
  • MRNA TREATMENT NANOPARTICLES
    Publication number: 20230193288
    Abstract: Provided herein are examples of mRNA treatment nanoparticles and methods of using them to treat a patient. An mRNA treatment nanoparticle may include one or more mRNAs encoding a tumor-specific antigen and an immunomodulatory agent; and a delivery vehicle molecule encapsulating the one or more mRNAs.
    Type: Application
    Filed: October 20, 2022
    Publication date: June 22, 2023
    Inventors: Samuel DEUTSCH, Daniel FRIMANNSSON, Nicole FAY, Colin McKINLAY
  • METHODS AND APPARATUSES FOR MANUFACTURING FOR REMOVING MATERIAL FROM A THERAPEUTIC COMPOSITION
    Publication number: 20210040472
    Abstract: Methods and apparatuses for making and using therapeutics, including in particular mRNA therapeutics, that separate double-stranded RNA from single-stranded RNA as part of a continuous flow. These methods and apparatuses may include formulation of an RNA therapeutic using a permeable insert integrated into a microfluidic path device. In particular, these methods and apparatuses may include formulation of an RNA therapeutic by removing dsRNA from a solution of RNA by within a microfluidic path device including a cellulose material.
    Type: Application
    Filed: August 10, 2020
    Publication date: February 11, 2021
    Inventors: Samuel DEUTSCH, Benjamin ELDRIDGE, Colin McKINLAY, Ximiao WEN, Sangeeta NATH, Igor KHANDROS, Robert EVANS
  • IMMOLATIVE CELL-PENETRATING COMPLEXES FOR NUCLEIC ACID DELIVERY
    Publication number: 20180028688
    Abstract: There are provided herein, inter alia, complexes, compositions and methods for the delivery of therapeutic, diagnostic and imaging agents, including nucleic acid, into a cell. The complexes, compositions and methods may facilitate complexation, protection, delivery and release of oligonucleotides and polyanionic cargos into target cells, tissues, and organs both in vitro and in vivo.
    Type: Application
    Filed: July 27, 2017
    Publication date: February 1, 2018
    Inventors: Robert M. Waymouth, Paul Wender, Jessica R. Vargas, Tim R. Blake, Colin McKinlay, Ronald Levy, Ole Audun Werner Haabeth, Nancy Benner, Katherine Near